(DRSK) Aptus Defined Risk - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US26922A3885 • Short-Term Bond
DRSK: Corporate Bonds, U.S. Stocks
Aptus Defined Risk ETF (DRSK) is an actively managed, hybrid strategy exchange-traded fund designed to balance fixed income and equity exposure. It allocates 75% to 95% of its assets to investment-grade corporate bonds, providing a stable foundation, while the remaining 5% to 25% is dedicated to U.S. equities with a focus on mitigating downside risk. This dual approach aims to offer a balanced risk-return profile, making it appealing in todays volatile markets.
The funds fixed income strategy focuses on high-quality corporate bonds, which typically offer predictable income and lower volatility compared to equities. Meanwhile, the equity portion employs options strategies to limit potential losses, a feature particularly attractive to risk-averse investors seeking equity exposure without extreme volatility.
DRSK is actively managed by experienced professionals who continuously assess market conditions to optimize the funds allocations and strategies. This active oversight allows the fund to adapt to shifting economic landscapes, aiming to preserve capital and generate steady returns. With an AUM of over $1.1 billion, DRSK is a sizable fund, indicating investor confidence and providing liquidity, which is crucial for ETFs to maintain efficient trading.
Investors seeking a diversified portfolio with both income generation and controlled equity exposure may find DRSK a compelling choice. Its structure is designed to navigate various market environments, offering a middle ground between the stability of bonds and the growth potential of stocks, supported by a robust investment approach.
Additional Sources for DRSK ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DRSK ETF Overview
Market Cap in USD | 1,138m |
Category | Short-Term Bond |
TER | 0.78% |
IPO / Inception | 2018-08-07 |
DRSK ETF Ratings
Growth 5y | 27.7% |
Fundamental | - |
Dividend | 37.3% |
Rel. Strength Industry | 9.32 |
Analysts | - |
Fair Price Momentum | 26.85 USD |
Fair Price DCF | - |
DRSK Dividends
Dividend Yield 12m | 3.28% |
Yield on Cost 5y | 3.82% |
Annual Growth 5y | -11.50% |
Payout Consistency | 89.2% |
DRSK Growth Ratios
Growth Correlation 3m | 64.1% |
Growth Correlation 12m | 85.9% |
Growth Correlation 5y | 1.9% |
CAGR 5y | 3.24% |
CAGR/Max DD 5y | 0.16 |
Sharpe Ratio 12m | 0.21 |
Alpha | 3.50 |
Beta | 0.40 |
Volatility | 6.58% |
Current Volume | 108.4k |
Average Volume 20d | 162.7k |
As of March 14, 2025, the stock is trading at USD 27.89 with a total of 108,405 shares traded.
Over the past week, the price has changed by -0.78%, over one month by -0.85%, over three months by +0.28% and over the past year by +9.31%.
Neither. Based on ValueRay Analyses, Aptus Defined Risk is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 27.71 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DRSK as of March 2025 is 26.85. This means that DRSK is currently overvalued and has a potential downside of -3.73%.
Aptus Defined Risk has no consensus analysts rating.
According to ValueRays Forecast Model, DRSK Aptus Defined Risk will be worth about 29.3 in March 2026. The stock is currently trading at 27.89. This means that the stock has a potential upside of +4.91%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 29.3 | 4.9% |